Seelos Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

Seelos Therapeutics, Inc. Finite-Lived Intangible Asset, Expected Amortization, Year Five

Seelos Therapeutics, Inc. had Finite-Lived Intangible Asset, Expected Amortization, Year Five of $303.90 thousand as of 2012-09-30, per its 10-Q filed 2012-11-08.

Discontinued › Notes › Intangible Assets › Goodwill and Other › Intangible Asset, Finite-Lived, after Accumulated Amortization, Estimated Amortization Expense, Fiscal Year Maturity

us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive · last filed 2012-11-08

• 2012-09-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $303.90K.
• 2012-06-30: Finite-Lived Intangible Asset, Expected Amortization, Year Five $303.90K.